February 2026 in “Clinical Traditional Medicine and Pharmacology” In this study, both Unani formulations tested were effective in managing Telogen Effluvium, with Itrifal Kishneezi and Roghan Amla showing slightly faster early results in reducing hair shedding, although overall efficacy between the two treatments was comparable.
January 2025 in “Indian Journal of Unani Medicine” This case study observed that a Unani medicine regimen significantly improved hair shedding and quality of life in a 24-year-old female with Telogen Effluvium following a febrile illness, showing potential effectiveness and safety in this context.
May 2024 in “International journal of science and research” This study found that local Unani formulations combined with Hair Rejuvenation Therapy led to significant hair regeneration in three Indian patients with androgenetic alopecia, suggesting potential relief and highlighting the need for larger trials to confirm these findings.
June 2025 in “International Journal of Research and Review” This review concluded that Unani medicine offers a promising holistic approach to managing androgenetic alopecia by focusing on humoral balance and follicular rejuvenation, but further scientific validation is needed for widespread clinical use.
February 2019 in “International journal of scientific reports” This case study observed that Unani medicine appeared effective for hair regrowth in a 16-year-old with alopecia areata after 45 days of treatment.
